日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phosphoinositide kinase PIKfyve inhibitor apilimod blocks hepatitis E virus infection

磷脂酰肌醇激酶 PIKfyve 抑制剂 apilimod 可阻断戊型肝炎病毒感染

Ring, Julian J; Schlienkamp, Sarah; Goussain Darido, Maria L; Zhang, Xin; Pinto Veiga, Olinda; Haase, Jil Alexandra; Richter, Emely; Gömer, André; Fu, Rebecca Menhua; Dao Thi, Viet Loan; Ulrich, Rainer G; Klöhn, Mara; Todt, Daniel; Bader, Verian; Winklhofer, Konstanze F; Kinast, Volker; Neyts, Johan; Kaptein, Suzanne J F; Steinmann, Eike; Brüggemann, Yannick

Interferon-induced immune signatures are associated with suppression of HEV infection in porcine cell culture models

干扰素诱导的免疫特征与猪细胞培养模型中戊型肝炎病毒感染的抑制相关。

Schlienkamp, Sarah; Veiga, Olinda Pinto; Gömer, André; Nörthemann, Luca; Sirkinti, Leyla; Frericks, Nicola; Sutter, Kathrin; Vondran, Florian W R; Hamprecht, Axel; Todt, Daniel; Steinmann, Eike; Kinast, Volker

Potential risk of porcine-derived pancreatic enzyme medication for the cross-species transmission of hepatitis E virus

猪源性胰酶药物存在跨物种传播戊型肝炎病毒的潜在风险

Frericks, Nicola; Kinast, Volker; Steinmann, Eike

The tyrosine kinase Yes1 is a druggable host factor of HEV.

酪氨酸激酶 Yes1 是 HEV 的一种可药物靶向的宿主因子

Haase Jil Alexandra, Baheerathan Abarna, Zhang Xin, Fu Rebecca Menhua, Nocke Maximilian Klaus, Decker Charlotte, Dao Thi Viet Loan, Todt Daniel, Neyts Johan, Kaptein Suzanne J F, Steinmann Eike, Kinast Volker